Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04555226 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Aug 2024 to Aug 2029v6 Show 5 more changesShow less
    • Study completion date: Aug 2029 to Aug 2032
    • Interventions: Chemoradiation (Radiation), Lymph node dissection (Procedure), Standard chemoradiation (Radiation) to Chemoradiation± pembrolizumab (Radiation), Lymph node dissection (Procedure), Standard chemoradiation±pembrolizumab (Radiation)
    • Eligibility criteria expanded, about 78 words
    • Collaborators: 22 to 23
    • Study description expanded, about 2 words
  2. Collaborators: 21 to 22v5
  3. Collaborators: 22 to 21v4
  4. Collaborators: 23 to 22v3
  5. Primary completion date: Dec 2022 to Aug 2024v2 Show 4 more changesShow less
    • Start date changed from estimate of Sep 2020 to Jan 11, 2021
    • Enrollment target: 413 to 452
    • Study completion date: Dec 2027 to Aug 2029
    • Collaborators: 20 to 23
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an national, prospective, multicenter and randomized clinical study designed to determine if patients with stage IIICr of cervical cancer have longer PFS and/or OS with lymph node dissection before CCRT when compared to CCRT.
Trial Details
NCT Number NCT04555226
Lead Sponsor Chongqing University Cancer Hospital
Collaborators: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Jiangxi Provincial Cancer Hospital, Anhui Provincial Cancer Hospital, The Second Affiliated Hospital of Harbin Medical University, Hebei Medical University Fourth Hospital, Zhejiang Cancer Hospital, Women's Hospital School Of Medicine Zhejiang University, Qilu Hospital of Shandong University, Fujian Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Cancer Hospital of Guizhou Province, West China Second University Hospital, Tongji Hospital, The Affiliated Ganzhou Hospital of Nanchang University, First Affiliated Hospital of Gannan Medical University, Gansu Provincial Maternal and Child Health Care Hospital, Third Affiliated Hospital of Xinjiang Medical University, Affiliated Cancer Hospital of Shantou University Medical College, Obstetrics & Gynecology Hospital of Fudan University, The Second Affiliated Hospital of Dalian Medical University, Fujian Maternity and Child Health Hospital, Shandong Cancer Hospital and Institute, Sun Yat-Sen University Cancer Center
Conditions
(from sponsor)		 Cervical Cancer
Related terms Uterine Cervical Neoplasms
Enrollment 452 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov